| ASSET | MONTH | % RETURN |
|---|---|---|
Immunitybio (IBRX) | June 2017 | 107.95% |
Option Care Health (OPCH) | June 2017 | 50% |
PTC Therapeutics (PTCT) | June 2017 | 45.82% |
Bausch Health Companies (BHC) | June 2017 | 43.57% |
Axsome Therapeutics (AXSM) | June 2017 | 42.86% |
Sunrun (RUN) | June 2017 | 40.99% |
Signet Jewelers (SIG) | June 2017 | 30.85% |
Catalyst Pharmaceuticals (CPRX) | June 2017 | 29.58% |
Amicus Therapeutics (FOLD) | June 2017 | 25.4% |
Cidara Therapeutics (CDTX) | June 2017 | 23.97% |
Bancorp (TBBK) | June 2017 | 23.25% |
Star Bulk Carriers (SBLK) | June 2017 | 22.72% |
iRhythm Technologies (IRTC) | June 2017 | 22.59% |
Travere Therapeutics (TVTX) | June 2017 | 21.64% |
Inventrust Properties (IVT) | June 2017 | 21.41% |
Worthington Industries (WOR) | June 2017 | 19.92% |
Credit Acceptance (CACC) | June 2017 | 19.25% |
Nelnet (NNI) | June 2017 | 19.16% |
Avis Budget (CAR) | June 2017 | 18.56% |
Ensign (ENSG) | June 2017 | 18.55% |
GDS (GDS) | June 2017 | 18.39% |
Acadia Healthcare (ACHC) | June 2017 | 18.28% |
IES (IESC) | June 2017 | 18.24% |
IAMGold (IAG) | June 2017 | 18.08% |
Terawulf (WULF) | June 2017 | 18% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
